[HTML][HTML] Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies
Chronic lymphocytic leukemia is a well-defined lymphoid neoplasm with very
heterogeneous biological and clinical behavior. The last decade has been remarkably …
heterogeneous biological and clinical behavior. The last decade has been remarkably …
[HTML][HTML] The spontaneous remission of cancer: Current insights and therapeutic significance
G Radha, M Lopus - Translational oncology, 2021 - Elsevier
Many diseases heal spontaneously. The common cold, for example, remedies itself within a
few days in people with an uncompromised immune system. If a disease with a poor …
few days in people with an uncompromised immune system. If a disease with a poor …
[HTML][HTML] Clonal evolution of high-risk chronic lymphocytic leukemia: A contemporary perspective
M Kwok, CJ Wu - Frontiers in oncology, 2021 - frontiersin.org
Clonal evolution represents the natural process through which cancer cells continuously
search for phenotypic advantages that enable them to develop and expand within …
search for phenotypic advantages that enable them to develop and expand within …
[HTML][HTML] Low humoral immune response and ineffective clearance of SARS-Cov-2 in a COVID-19 patient with CLL during a 69-day follow-up
X Ye, X Xiao, B Li, W Zhu, Y Li, J Wu, X Huang… - Frontiers in …, 2020 - frontiersin.org
Background: A recent outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-
Cov-2), which began in Wuhan, China, with a high level of human-to-human transmission …
Cov-2), which began in Wuhan, China, with a high level of human-to-human transmission …
[HTML][HTML] Targeting the p53 pathway in CLL: State of the art and future perspectives
Simple Summary The p53 pathway plays a fundamental role in preventing the accumulation
of unrepaired DNA damage. Unsurprisingly, cancer cells often break this protective barrier …
of unrepaired DNA damage. Unsurprisingly, cancer cells often break this protective barrier …
Integrative epigenomics in chronic lymphocytic leukaemia: Biological insights and clinical applications
M Kulis, JI Martin‐Subero - British Journal of Haematology, 2023 - Wiley Online Library
Chronic lymphocytic leukaemia (CLL) is not only characterised by driver genetic alterations
but by extensive epigenetic changes. Over the last decade, epigenomic studies have …
but by extensive epigenetic changes. Over the last decade, epigenomic studies have …
The end of the beginning: application of single-cell sequencing to chronic lymphocytic leukemia
A Nagler, CJ Wu - Blood, 2023 - ashpublications.org
Single-cell analysis has emerged over the past decade as a transformative technology
informative for the systematic analysis of complex cell populations such as in cancers and …
informative for the systematic analysis of complex cell populations such as in cancers and …
Biological, prognostic and therapeutic impact of the epigenome in CLL
A Maiques-Diaz, JI Martin-Subero - Seminars in Hematology, 2023 - Elsevier
Chronic lymphocytic leukemia (CLL) is characterized by widespread alterations in the
genetic and epigenetic landscapes which seem to underlie the variable clinical …
genetic and epigenetic landscapes which seem to underlie the variable clinical …
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature.
I Del Giudice, LV Cappelli, J Delgado… - British Journal of …, 2023 - search.ebscohost.com
Thirty-seven patients were alive at the last follow-up, 13 had died (two dementia-related
causes, one pneumonia, one warfarin-related bleeding, one ovarian cancer, eight because …
causes, one pneumonia, one warfarin-related bleeding, one ovarian cancer, eight because …
[HTML][HTML] Minimal residual disease: premises before promises
B Chin-Yee - Biology & Philosophy, 2024 - Springer
Minimal residual disease (MRD), a measure of residual cancer cells, is a concept
increasingly employed in precision oncology, touted as a key predictive biomarker to guide …
increasingly employed in precision oncology, touted as a key predictive biomarker to guide …